Kymera Therapeutics (KYMR) Earnings Date & Reports

A.I. Advisor
published Earnings

KYMR is expected to report earnings to fall 1.26% to -68 cents per share on August 02

Kymera Therapeutics KYMR Stock Earnings Reports
Q2'24
Est.
$-0.68
Q1'24
Beat
by $0.02
Q4'23
Beat
by $0.15
Q3'23
Missed
by $0.26
Q2'23
Missed
by $0.03
The last earnings report on May 02 showed earnings per share of -68 cents, beating the estimate of -70 cents. With 436.53K shares outstanding, the current market capitalization sits at 2.64B.
View a ticker or compare two or three
KYMR
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biotechnology company, which engages in curing untreatable diseases and focuses on discovering and developing novel small molecule therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
200 Arsenal Yards Boulevard
Phone
+1 857 285-5300
Employees
187
Web
https://www.kymeratx.com